Human tissue factor pathway inhibitor-2 does not bind or inhibit activated matrix metalloproteinase-1

被引:15
作者
Du, X [1 ]
Chand, HS [1 ]
Kisiel, W [1 ]
机构
[1] Univ New Mexico, Ctr Hlth Sci, Dept Pathol, Albuquerque, NM 87131 USA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS | 2003年 / 1621卷 / 03期
关键词
TFPI-2; matrix metalloproteinase; extracellular matrix;
D O I
10.1016/S0304-4165(03)00074-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tissue factor pathway inhibitor-2 (TFPI-2) is a Kunitz-type serine proteinase inhibitor associated with the extracellular matrices of vascular cells. A recent report provided in vitro evidence that TFPI-2 may be a novel inhibitor of the matrix metalloproteinases MMP-1, MMP-13, MMP-2 and MMP-9. In studies aimed at identifying the structural elements of TFPI-2 mediating the putative inhibition of the above MMPs, we re-examined the ability of native TFPI-2 to form complexes with MMP-2, MMP-9 and MMP-1, as well as assess its ability to inhibit the proteolytic activity of the interstitial collagenase, activated MMP-1. We report here that TFPI-2 failed to form complexes with MMP-2, MMP-9 and MMP-1 as revealed in immunoprecipitation and ligand blotting studies. In addition, TFPI-2 had no influence on the proteolytic activity of activated MMP-1 towards triple-helical collagen. These data provide presumptive evidence that TFPI-2 does not bind to MMP-2, MMP-9 and MMP-1, or regulate MMP-1, in the extracellular matrix. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:242 / 245
页数:4
相关论文
共 13 条
[1]  
FOWLKES JL, 1994, J BIOL CHEM, V269, P25742
[2]   Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis [J].
Herman, MP ;
Sukhova, GK ;
Kisiel, W ;
Foster, D ;
Kehry, MR ;
Libby, P ;
Schönbeck, U .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (09) :1117-1126
[3]   Quantification and characterization of human endothelial cell-derived tissue factor pathway inhibitor-2 [J].
Iino, M ;
Foster, DC ;
Kisiel, W .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (01) :40-46
[4]   Tissue factor pathway inhibitor-2 suppresses the production of active matrix metalloproteinase-2 and is down-regulated in cells harboring activated ras oncogenes [J].
Izumi, H ;
Takahashi, C ;
Oh, J ;
Noda, M .
FEBS LETTERS, 2000, 481 (01) :31-36
[5]   Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor [J].
Petersen, LC ;
Sprecher, CA ;
Foster, DC ;
Blumberg, H ;
Hamamoto, T ;
Kisiel, W .
BIOCHEMISTRY, 1996, 35 (01) :266-272
[6]   Extracellular matrix-associated serine protease inhibitors (M(r) 33,000, 31,000, and 27,000) are single-gene products with differential glycosylation: cDNA cloning of the 33-kDa inhibitor reveals its identity to tissue factor pathway inhibitor-2 [J].
Rao, CN ;
Reddy, P ;
Liu, YY ;
OToole, E ;
Reeder, D ;
Foster, DC ;
Kisiel, W ;
Woodley, DT .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1996, 335 (01) :82-92
[7]   PARTIAL CHARACTERIZATION OF NOVEL SERINE PROTEINASE-INHIBITORS FROM HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLS [J].
RAO, CN ;
GOMEZ, DE ;
WOODLEY, DT ;
THORGEIRSSON, UP .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1995, 319 (01) :55-62
[8]   Regulation of ProMMP-1 and ProMMP-3 activation by tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor [J].
Rao, CN ;
Mohanam, S ;
Puppala, A ;
Rao, JS .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 255 (01) :94-98
[9]  
Rao CN, 1998, INT J CANCER, V76, P749, DOI 10.1002/(SICI)1097-0215(19980529)76:5<749::AID-IJC21>3.0.CO
[10]  
2-Y